4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030724
EVP & Chief R & QA Officer sold 4,647 shares at an average $46.06 ($214,026)
- EVP & Chief R & QA Officer acquired 4,808 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…